{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:28:40Z","timestamp":1760369320650,"version":"3.41.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>5,6-Methylenedioxy-2-aminoindane (MDAI) has become a common substitute for (\u00b1)-3,4-methylenedioxymethamphetamine (MDMA) in Ecstasy. MDAI is known to produce MDMA-like discriminative stimulus effects, but it is not known whether MDAI has psychostimulant or hallucinogen-like effects. MDAI was tested for locomotor stimulant effects in mice and subsequently for discriminative stimulus effects in rats trained to discriminate cocaine (10\u2009mg\/kg, intraperitoneally), methamphetamine (1\u2009mg\/kg, intraperitoneally), \u00b1MDMA (1.5\u2009mg\/kg, intraperitoneally), or (\u2212)-2,5-dimethoxy-4-methylamphetamine hydrochloride (0.5\u2009mg\/kg, intraperitoneally) from saline. The ability of MDAI to produce conditioned place preference was also tested in mice. MDAI (3 to 30\u2009mg\/kg) depressed locomotor activity from 10 to 60\u2009min. A rebound stimulant effect was observed at 1 to 3.5\u2009h following 30\u2009mg\/kg. Lethality occurred in 8\/8 mice following 100\u2009mg\/kg MDAI. Similarly, MDMA depressed locomotor activity immediately following the administration of 0.25\u2009mg\/kg and stimulant effects were observed 50\u201370\u2009min following the administration of 0.5 and 1\u2009mg\/kg. MDAI fully substituted for the discriminative stimulus effects of MDMA (2.5\u2009mg\/kg), (\u2212)-2,5-dimethoxy-4-methylamphetamine hydrochloride (5\u2009mg\/kg), and cocaine (7.5\u2009mg\/kg), but produced only 73% methamphetamine-appropriate responding at a dose that suppressed responding (7.5\u2009mg\/kg). MDAI produced tremors at 10\u2009mg\/kg in one methamphetamine-trained rat. MDAI produced conditioned place preference from 0.3 to 10\u2009mg\/kg. The effects of MDAI on locomotor activity and drug discrimination were similar to those produced by MDMA, having both psychostimulant-like and hallucinogen-like effects; thus, MDAI may have similar abuse potential as MDMA.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000237","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T17:18:27Z","timestamp":1461086307000},"page":"497-505","source":"Crossref","is-referenced-by-count":19,"title":["Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents"],"prefix":"10.1097","volume":"27","author":[{"given":"Michael B.","family":"Gatch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean B.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0091-3057(90)90538-S","article-title":"Methylenedioxymethamphetamine\u2019s capacity to establish place preferences and modify intake of an alcoholic beverage","volume":"37","author":"Bilsky","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02244073","article-title":"Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine","volume":"103","author":"Callahan","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"R3-20230910","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3565(25)12637-2","article-title":"Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats","volume":"254","author":"Callaway","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1021\/jm901189z","article-title":"Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction","volume":"52","author":"Carroll","year":"2009","journal-title":"J Med Chem"},{"key":"R5-20230910","first-page":"43","article-title":"Characterization of the \u2018Methylenedioxy-2-aminoindans\u2019","volume":"8","author":"Casale","year":"2011","journal-title":"Microgram J"},{"key":"R6-20230910","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0278-5846(95)00231-6","article-title":"Subjective reports on the effects of the MDMA (\u2018ecstasy\u2019) experience in humans","volume":"19","author":"Cohen","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"R7-20230910","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0149-7634(03)00031-9","volume":"27","author":"Cole","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"R8-20230910","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hup.2298","article-title":"MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; \u2018sparkle\u2019; \u2018mindy\u2019) toxicity: a brief overview and update","volume":"28","author":"Corkery","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1360-0443.2009.02649.x","article-title":"Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study","volume":"104","author":"Cottler","year":"2009","journal-title":"Addiction"},{"key":"R10-20230910","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1369-1600.2009.00173.x","article-title":"Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence","volume":"14","author":"Daza-Losada","year":"2009","journal-title":"Addiction Biol"},{"key":"R11-20230910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.09.009","article-title":"Is ecstasy a drug of dependence?","volume":"107","author":"Degenhardt","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2014.11.006","article-title":"Abuse liability of the dietary supplement dimethylamylamine","volume":"146","author":"Dolan","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2014.04.017","article-title":"A 3-year review of new psychoactive substances in casework","volume":"243C","author":"Elliott","year":"2014","journal-title":"Forensic Sci Int"},{"key":"R14-20230910","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00213-013-3303-6","article-title":"Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function","volume":"231","author":"Eshleman","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hup.1255","article-title":"5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to \u2018legal high\u2019","volume":"7","author":"Gallagher","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00213-009-1501-z","article-title":"Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats","volume":"204","author":"Gatch","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-20230910","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.111.179705","article-title":"Abuse liability profile of three substituted tryptamines","volume":"338","author":"Gatch","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of \u2018Bath Salt\u2019 cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav Pharmacol"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.115.223586","article-title":"Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives","volume":"354","author":"Gatch","year":"2015a","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00213-014-3755-3","article-title":"Discriminative and locomotor effects of five synthetic cathinones in rats and mice","volume":"232","author":"Gatch","year":"2015b","journal-title":"Psychopharmacology (Berl)"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00634450","article-title":"A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA","volume":"99","author":"Gold","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"R22-20230910","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/1064-1297.8.3.415","article-title":"A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (\u00b1)-MDMA in rats","volume":"8","author":"Goodwin","year":"2000","journal-title":"Exp Clin Psychopharmacol"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0091-3057(03)00029-7","article-title":"Serotonergic-dopaminergic mediation of MDMA\u2019s discriminative stimulus effects in a three-choice discrimination","volume":"74","author":"Goodwin","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"R24-20230910","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0041-008X(73)80016-X","article-title":"Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals","volume":"25","author":"Hardman","year":"1973","journal-title":"Toxicol Appl Pharmacol"},{"key":"R25-20230910","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2013.11.011","article-title":"A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA","volume":"116","author":"Harper","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(91)90659-E","article-title":"[3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues","volume":"200","author":"Johnson","year":"1991a","journal-title":"Eur J Pharmacol"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/jm00109a020","article-title":"Synthesis and pharmacological examination of 1(-3-methoxy-4-methylphenyl)-2-amino propane and 5-methoxy-6-methyl-2-aminosindan: Similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)","volume":"34","author":"Johnson","year":"1991b","journal-title":"J Med Chem"},{"key":"R29-20230910","first-page":"917","article-title":"The pharmacology and toxicology of \u2018ecstasy\u2019 (MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"Can Med Assoc J"},{"key":"R30-20230910","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130000667","article-title":"Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents","volume":"154","author":"Katz","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3565(25)12606-2","article-title":"Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys","volume":"254","author":"Kleven","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"R32-20230910","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.drugalcdep.2004.01.005","article-title":"Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization","volume":"74","author":"Khorana","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00213-006-0523-z","article-title":"Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine","volume":"189","author":"Kueh","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J Anal Toxicol"},{"key":"R36-20230910","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/jm00164a037","article-title":"Nonneurotoxic tetralin and Indan analogues of 3,4-(methylenedioxy)amphetamine","volume":"33","author":"Nichols","year":"1990","journal-title":"J Med Chem"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00212770","article-title":"Drug discrimination studies with MDMA and amphetamine","volume":"95","author":"Oberlender","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s002130050714","article-title":"Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance","volume":"139","author":"Parrot","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"R39-20230910","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2013.06.005","article-title":"Involvement of 5-hydroxytryptamine 5-HT3 serotonergic receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA","volume":"714","author":"Roger-S\u00e1nchez","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"R40-20230910","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dta.318","article-title":"Aminoindanes \u2013 the next wave of \u2018legal highs\u2019?","volume":"3","author":"Sainsbury","year":"2011","journal-title":"Drug Test Anal"},{"key":"R41-20230910","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-3565(25)22189-9","article-title":"Lysergic acid diethylamine and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis","volume":"246","author":"Sanders-Bush","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R42-20230910","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0091-3057(97)00415-2","article-title":"MDMA-like stimulus effects of hallucinogens in male Fawn-Hooded rats","volume":"59","author":"Schechter","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"R43-20230910","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neubiorev.2010.12.010","article-title":"MDMA (\u2018Ecstasy\u2019) abuse as an example of dopamine neuroplasticity","volume":"35","author":"Schenk","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"R44-20230910","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.addbeh.2004.02.022","article-title":"Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy\/MDMA users: a WWW study","volume":"29","author":"Scholeya","year":"2004","journal-title":"Addict Behav"},{"key":"R45-20230910","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","article-title":"Monoamine transporter and receptor interaction profiles of a new series of designer cathinones","volume":"79","author":"Simmler","year":"2014a","journal-title":"Neuropharmacol"},{"key":"R46-20230910","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.bcp.2014.01.024","article-title":"Pharmacological profiles of aminoindanes, piperazines, and pipradol derivatives","volume":"88","author":"Simmler","year":"2014b","journal-title":"Biochem Pharmacol"},{"key":"R47-20230910","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0022-3565(24)37511-1","article-title":"Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs","volume":"285","author":"Tidey","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R48-20230910","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jat\/bku021","article-title":"Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine","volume":"38","author":"Uralets","year":"2014","journal-title":"J Anal Toxicol"},{"key":"R49-20230910","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1360-0443.2010.03130.x","article-title":"Mephedrone, new kid for the chop?","volume":"106","author":"Winstock","year":"2012","journal-title":"Addiction"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008877-201609000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:24:17Z","timestamp":1748895857000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008877-201609000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000237","relation":{},"ISSN":["0955-8810"],"issn-type":[{"type":"print","value":"0955-8810"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}